Published in

ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 3(33), 2020

DOI: 10.1590/0102-672020200003e1535

Links

Tools

Export citation

Search in Google Scholar

Brazilian Gastric Cancer Association Guidelines (Part 1): An Update on Diagnosis, Staging, Endoscopic Treatment and Follow-Up

Journal article published in 2020 by Leandro Cardoso Barchi ORCID, Marcus Fernando Kodama Pertille Ramos ORCID, Osmar Kenji Yagi ORCID, Donato Roberto Mucerino ORCID, Claudio José Caldas Bresciani ORCID, Ulysses Ribeiro Júnior ORCID, Nelson Adami Andreollo ORCID, Paulo Pimentel Assumpção ORCID, Antônio Carlos Weston ORCID, Ramiro Colleoni Neto ORCID, Bruno Zilberstein ORCID, Álvaro Antônio Bandeira Ferraz, Amir Zeide Charruf, André Roncon Dias, André Brandalise and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

ABSTRACT Background: The II Brazilian Consensus on Gastric Cancer by the Brazilian Gastric Cancer Association (ABCG) was recently published. On this occasion, several experts in gastric cancer expressed their opinion before the statements presented. Aim: To present the ABCG Guidelines (part 1) regarding the diagnosis, staging, endoscopic treatment and follow-up of gastric cancer patients. Methods: To forge these Guidelines, the authors carried out an extensive and current review regarding each statement present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases with the following descriptors: gastric cancer, staging, endoscopic treatment and follow-up. In addition, each statement was classified according to the level of evidence and degree of recommendation. Results: Of the 24 statements, two (8.3%) were classified with level of evidence A, 11 (45.8%) with B and 11 (45.8%) with C. As for the degree of recommendation, six (25%) statements obtained grade of recommendation 1, nine (37.5%) recommendation 2a, six (25%) 2b and three (12.5%) grade 3. Conclusion: The guidelines presented here are intended to assist professionals working in the fight against gastric cancer with relevant and current information, granting them to be applied in the daily medical practice.